Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 18, 2023 - Issue
Submit an article Journal homepage
201
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Exercise Performance of Lowlanders with Chronic Obstructive Pulmonary Disease Acutely Exposed to 2048 m: A Randomized Cross-Over Trial

Konstantinos Bitos1 University Hospital Zurich, Department of Respiratory Medicine, Zurich, Switzerland
,
Tobias Kuehne1 University Hospital Zurich, Department of Respiratory Medicine, Zurich, Switzerland
,
Tsogyal D Latshang1 University Hospital Zurich, Department of Respiratory Medicine, Zurich, Switzerland
,
Sayaka S Aeschbacher1 University Hospital Zurich, Department of Respiratory Medicine, Zurich, Switzerland
,
Fabienne Huber1 University Hospital Zurich, Department of Respiratory Medicine, Zurich, Switzerland
,
Deborah Flueck1 University Hospital Zurich, Department of Respiratory Medicine, Zurich, Switzerland
,
Elisabeth D Hasler1 University Hospital Zurich, Department of Respiratory Medicine, Zurich, Switzerland
,
Philipp M Scheiwiller1 University Hospital Zurich, Department of Respiratory Medicine, Zurich, Switzerland
,
Mona Lichtblau1 University Hospital Zurich, Department of Respiratory Medicine, Zurich, Switzerland
,
Silvia Ulrich1 University Hospital Zurich, Department of Respiratory Medicine, Zurich, SwitzerlandORCID Iconhttps://orcid.org/0000-0002-5250-5022
ORCID Icon,
Konrad E Bloch1 University Hospital Zurich, Department of Respiratory Medicine, Zurich, Switzerland
&
Michael Furian1 University Hospital Zurich, Department of Respiratory Medicine, Zurich, Switzerland;2 Swiss University of Traditional Chinese Medicine, Research Department, Bad Zurzach, SwitzerlandCorrespondence[email protected]
 show all
Pages 1753-1762 | Received 08 Dec 2022, Accepted 14 Jun 2023, Published online: 17 Aug 2023

References

  • Vogiatzis I, Zakynthinos S. Factors limiting exercise tolerance in chronic lung diseases. Compr Physiol. 2012;2:1779–1817. doi:10.1002/cphy.c110015
  • Agusti AGN, Barbera JA, Roca J, Wagner PD, Guitart R, Rodriguez-Roisin R. Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease. Chest. 1990;97:268–275. doi:10.1378/chest.97.2.268
  • Mahler DA, Brent BN, Loke J, Zaret BL, Matthay RA. Right ventricular performance and central circulatory hemodynamics during upright exercise in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1984;130(5):722–729. doi:10.1164/arrd.1984.130.5.722
  • Debigaré R, Maltais F. The major limitation to exercise performance in COPD is lower limb muscle dysfunction. J Appl Physiol. 2008;105(2):751–753. doi:10.1152/japplphysiol.90336.2008a
  • Gallagher CG. Exercise limitation and clinical exercise testing in chronic obstructive pulmonary disease. Clin Chest Med. 1994;15(2):305–326. doi:10.1016/S0272-5231(21)01075-3
  • Wyatt FB. Physiological responses to altitude: a brief review. JEPonline. 2014;17(1):90–96.
  • Furian M, Hartmann SE, Latshang TD, et al. Exercise performance of lowlanders with COPD at 2590 m: data from a randomized trial. Respiration. 2018;95(6):422–432. doi:10.1159/000486450
  • Furian M, Flueck D, Latshang TD, et al. Exercise performance and symptoms in lowlanders with COPD ascending to moderate altitude: randomized trial. Int J Chron Obstruct Pulmon Dis. 2018;13:3529–3538. doi:10.2147/COPD.S173039
  • Kelly PT, Swanney MP, Stanton JD, Frampton C, Peters MJ, Beckert LE. Resting and exercise response to altitude in patients with chronic obstructive pulmonary disease. Aviat Space Environ Med. 2009;80(2):102–107. doi:10.3357/asem.2434.2009
  • Furian M, Mademilov M, Buergin A, et al. Acetazolamide to Prevent Adverse Altitude Effects in COPD and Healthy Adults. NEJM Evidence. 2022;1(1):EVIDoa2100006. doi:10.1056/EVIDoa2100006
  • Tan L, Latshang TD, Aeschbacher SS, et al. Effect of Nocturnal Oxygen Therapy on Nocturnal Hypoxemia and Sleep Apnea Among Patients With Chronic Obstructive Pulmonary Disease Traveling to 2048 Meters: a Randomized Clinical Trial. JAMA network open. 2020;3(6):e207940–e207940. doi:10.1001/jamanetworkopen.2020.7940
  • Gutweniger S, Latshang TD, Aeschbacher SS, et al. Effect of nocturnal oxygen therapy on exercise performance of COPD patients at 2048 m: data from a randomized clinical trial. Sci Rep. 2021;11(1):20355. doi:10.1038/s41598-021-98395-w
  • Lichtblau M, Latshang TD, Aeschbacher SS, et al. Effect of Nocturnal Oxygen Therapy on Daytime Pulmonary Hemodynamics in Patients With Chronic Obstructive Pulmonary Disease Traveling to Altitude: a Randomized Controlled Trial. Front Physiol. 2021;12:689863. doi:10.3389/fphys.2021.689863
  • Bisang M, Latshang TD, Aeschbacher SS, et al. Nocturnal Heart Rate and Cardiac Repolarization in Lowlanders With Chronic Obstructive Pulmonary Disease at High Altitude: data From a Randomized, Placebo-Controlled Trial of Nocturnal Oxygen Therapy. Clinical Trial. 2021;8:129.
  • Singh D, Agusti A, Anzueto A, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-2019
  • Ross RM. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211–277. doi:10.1164/rccm.167.2.211
  • Koch B, Schaper C, Ittermann T, et al. Reference values for cardiopulmonary exercise testing in healthy volunteers: the SHIP study. Eur Respir J. 2009;33(2):389–397. doi:10.1183/09031936.00074208
  • Borg E, Kaijser L. A comparison between three rating scales for perceived exertion and two different work tests. Scand J Med Sci Sports. 2006;16(1):57–69. doi:10.1111/j.1600-0838.2005.00448.x
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
  • Conroy RM. What hypotheses do “nonparametric” two-group tests actually test. Stata J. 2012;12(2):182–190. doi:10.1177/1536867X1201200202
  • Graham WG, Houston CS. Short-term adaptation to moderate altitude. Patients with chronic obstructive pulmonary disease. JAMA. 1978;240(14):1491–1494. doi:10.1001/jama.1978.03290140033017
  • Kind R, Furian M, Buergin A, et al. Effects of Acetazolamide on exercise performance in patients with COPD at high altitude. RCT. 2019;54(suppl 63):A1631.
  • Mourot L. Limitation of Maximal Heart Rate in Hypoxia: mechanisms and Clinical Importance. Review. 2018;9(972). doi:10.3389/fphys.2018.00972

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.